Emerging Markets: The Next Growth Frontier
Why do emerging markets matter now? Rapid healthcare investments in China, India, Brazil, Southeast Asia, Latin America, and Africa are creating high-demand environments for cost-effective, AI-enhanced imaging. With millions of new cancer cases emerging annually and rapidly expanding imaging volumes, these regions represent one of the largest untapped opportunities for scalable AI diagnostics.
Recent initiatives-such as NIRAMAI's partnership with the Punjab Government and Roche Pharma India, Intel's research center launch in Hyderabad, and Siemens Healthineers' EUR 160 million innovation hub investment in Bengaluru-highlight the accelerating momentum.

Challenges: Physician Hesitancy and Perceptions of Clinical Risk
Despite growing adoption, some physicians remain reluctant to embrace AI over concerns regarding trust, tech over-reliance, and perceived threats to human-centered diagnostics. Yet as AI systems demonstrate superior accuracy in tasks such as tumor detection and workflow optimization, confidence is increasing. Radiologists and specialists are increasingly recognizing AI as an augmentative tool, not a replacement.

Market Ecosystem: Software Dominates, Hospitals Lead Adoption
Software commanded the largest market share in 2023 due to its role in advanced diagnostics, workflow optimization, and real-time analytics. Deep learning algorithms now routinely outperform traditional diagnostic approaches, reaching >90% accuracy in carcinoma detection.
Hospitals were the leading end users in 2023, driven by strong IT infrastructure, access to large imaging datasets, and rising adoption of AI for complex cases-including oncology, neurology, and cardiology.
North America maintained global leadership, fueled by high chronic disease prevalence, strong funding for ethical AI research, and significant investments in AI-driven health infrastructure.

Key Industry Players
Market leadership is defined by both global technology firms and fast-growing innovators, including:
Microsoft, NVIDIA Corporation, Merative, Intel Corporation, Google, Siemens Healthineers, GE HealthCare, Digital Diagnostics Inc., Advanced Micro Devices, Butterfly Network, Lunit, Brainomix, Nano-X Imaging, Enlitic, icometrix, Aidence, Therapixel, HeartFlow, InformAI, and others.

Recent Strategic Developments

• July 2024 - Microsoft partnered with Mass General Brigham and the University of Wisconsin to enhance AI models for medical imaging, boosting radiologist efficiency.
• March 2024 - Microsoft and NVIDIA expanded collaboration integrating Azure AI with the DGX Cloud and Clara suite.
• July 2024 - GE HealthCare teamed with AWS to accelerate AI-based diagnostic models.
• November 2023 - NVIDIA and the National Health Research Institute (Taiwan) adopted NVIDIA's Blackwell platform for advanced biomedical research.
• November 2023 - Merative and Indica Labs integrated digital pathology with imaging systems to unify patient data and AI-driven analysis.

Market Insight: Why This Matters for Global Decision-Makers
As healthcare systems face rising patient loads, talent shortages, and cost pressures, AI in medical imaging is transitioning from optional innovation to strategic necessity. AI-driven insights are reshaping clinical pathways, enabling earlier interventions, reducing diagnostic variability, and strengthening system-wide capacity.
For technology leaders, investors, and healthcare executives, the next five years represent a critical window to leverage AI-driven imaging as a competitive differentiator across care delivery, patient outcomes, and operational efficiency.

Inquire Now!

Discover Connected Healthcare Market Opportunities:
Artificial Intelligence in Medical Diagnostics Market
AI in Pathology Market
Ultrasound AI Market
Computer Vision in Healthcare Market
Digital Pathology Market

Get access to the latest updates on Top Companies in Artificial Intelligence (AI) in Medical Imaging Artificial Intelligence (AI) in Medical Imaging Market Size

CONTACT: About MarketsandMarketsTM MarketsandMarketsTM has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarketsTM is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStoreTM, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit TM or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarketsTM INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email:... Visit Our Website: